Intrinsiqs

Is MapLight Therapeutics, Inc. overvalued?

MapLight Therapeutics, Inc. (MPLT) — key valuation metrics and fundamentals.

No verdict
Price
$13.41
Fair value
Current P/E
Normal P/E
Market cap
$548.3M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares MPLT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 6 Aug 2026.